FDA.gov: This is the first set of warning letters being issued to firms who have not submitted premarket applications to the FDA and are continuing to sell or distribute unauthorized ENDS after Sept. 9, 2020.
FDA.gov: This is the first set of warning letters being issued to firms who have not submitted premarket applications to the FDA and are continuing to sell or distribute unauthorized ENDS after Sept. 9, 2020.